|
ORIC ORIC Pharmaceuticals Inc 1796280 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-35,767,000.00 |
| Balance Sheet |
|
Current Assets
|
$290,233,000.00 |
|
Assets
|
$436,762,000.00 |
|
Current Liabilities
|
$17,771,000.00 |
|
Liabilities
|
$21,205,000.00 |
|
Equity
|
$415,557,000.00 |
|
Shares Out
|
103486412.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-32,438,000.00 |
|
Investing Cash Flow
|
$-17,975,000.00 |
| Market Analysis |
Market Cap
|
$1,204,581,835.68 |
|
Price
|
$10.63 |
|
BVPS
|
4.02 |
|
PB
|
2.90 |
|
EPS
|
-0.34 |
|
FCF
|
$-32,440,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:26 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:22 |
|
| Jan |
Feb |
Mar |
|
|
|
|
2026-02-23 |
-0.30 |
|
| Apr |
May |
Jun |
|
|
|
|
2026-05-04 |
-0.34 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-12 |
-0.47 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-13 |
-0.33 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view ORIC documents filed with the SEC.
ORIC Filings
Clear
